Skip to main content
. 2015 Jul;21(7):1135–1143. doi: 10.3201/eid2107.150522

Table 1. Characteristics of Ebola virus samples from selected patients, Liberia, September 2014–February 2015*.

Sample ID Patient age, y/sex County of residence Test date Sample type Average Ct value†
LIBR10054 53/M Bomi 2014 Sep 23 Plasma 20.5
LIBR10053 42/NA Not Available 2014 Oct 1 NA 22
LIBR0058 67/M Rivercess 2014 Nov 5 NA 22
LIBR0059 27/M Rivercess 2014 Nov 5 NA 22
LIBR0073 27/M Grand Bassa 2014 Nov 6 Plasma 18.5
LIBR0067 29/NA Bomi 2014 Nov 6 Plasma 21
LIBR0063 3/F Montesserrado 2014 Nov 6 Oral swab 17.5
LIBR0093 47/M Montesserrado 2014 Nov 6 Plasma 15.5
LIBR0092 18/F Montesserrado 2014 Nov 8 Plasma 21
LIBR0090 62/F Margibi 2014 Nov 8 Plasma 22
LIBR0116 4/F Grand Bassa 2014 Nov 10 Plasma 19
LIBR0168 15/M Bomi 2014 Nov 13 Plasma 22.5
LIBR0176 42/M Montesserrado 2014 Nov 14 Oral swab 22.5
LIBR0173 64/M Montesserrado 2014 Nov 14 Oral swab 22
LIBR0286 9/F Grand Cape Mount 2014 Nov 22 Plasma 22
LIBR0333 35/F Grand Cape Mount 2014 Nov 25 Plasma 19.5
LIBR0423 45/F Montesserrado 2014 Dec 3 Plasma 21.5
LIBR0430 1/M Grand Bassa 2014 Dec 3 Oral swab 23.5
LIBR0503 8/F Sinoe 2014 Dec 10 Plasma 23
LIBR0505 29/F Sinoe 2014 Dec 10 Plasma 25
LIBR0605 2/M Montesserrado 2014 Dec 20 Oral swab 23
LIBR0624 53/M Montesserrado 2014 Dec 22 Plasma 19.5
LIBR0993 33/M Montesserrado 2015 Jan 20 Plasma 19.5
LIBR1195 35/M Margibi 2015 Feb 2 Oral swab 22.5
LIBR1413 56 M Montesserrado 2015 Feb 14 Plasma 22.5

*Ct, cycle threshold; ID, identification; NA, not available.
†Ct values used as indicator of viral load obtained from 2 diagnostic assays performed on all samples (Kulesh-TM and Kulesh-MGB [9]).

HHS Vulnerability Disclosure